Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Revenue | 8.44B | 6.73B | 4.66B | 2.58B | 2.47B |
Cost of Revenue | 1.23B | 3.51B | 2.54B | 1.32B | 1.39B |
Gross Profit | 7.20B | 3.22B | 2.12B | 1.26B | 1.08B |
Operating Expenses | 6.21B | 3.38B | 5.91B | 4.88B | 2.10B |
Selling, General & Admin | 2.18B | 2.32B | 5.11B | 4.39B | 1.59B |
Research & Development | 946.63M | 914.15M | 729.67M | 413.37M | 396.69M |
Other Operating Expenses | 3.08B | 146.74M | 74.84M | 73.13M | 114.57M |
Operating Income | 997.43M | -113.93M | -3.80B | -3.61B | -1.02B |
Other Expenses / Income | 1.34B | 669.94M | 155.61M | 163.01M | -535.74M |
Before Tax Income | 2.33B | 507.94M | -3.64B | -3.45B | -1.56B |
Income Tax Expenses | 106.80M | 96.03M | 14.19M | 19.34M | -14.68M |
Net Income | 2.21B | 406.76M | -3.65B | -3.47B | -1.54B |
Interest Expenses | N/A | 175.00K | 40.00K | 8.37M | 40.00M |
Basic Shares Outstanding | 1.11B | 1.08B | 672.30M | 1.09B | 1.09B |
Diluted Shares Outstanding | 1.06B | 1.08B | 672.30M | 1.09B | 1.09B |
EBITDA | 2.41B | -74.14M | -3.73B | -3.38B | -1.45B |
EBITDA Margin | 28.55% | -1.10% | -80.06% | -130.95% | -58.46% |
EBIT | 2.32B | 502.97M | -3.64B | -3.44B | -1.52B |
EBIT Margin | 27.50% | 7.47% | -78.17% | -133.42% | -61.31% |
Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |